Correspondence
Immunology and Cell Biology (2008) 86, 633–634; doi:10.1038/icb.2008.64; published online 9 September 2008
Reply to 'Response to Milland et al.: Carbohydrate residues downstream of the terminal gal
(1,3)gal epitope modulate the specificity of xenoreactive antibodies'
Julie Milland1, Elizabeth Yuriev2, Pei-Xiang Xing3, Ian F C McKenzie1, Paul A Ramsland3, Dale Christiansen1 and Mauro S Sandrin1
- 1Department of Surgery (Austin Health), University of Melbourne, Heidelberg, Australia
- 2Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, Parkville, Australia
- 3Structural Immunology and Cancer Immunotherapy Laboratories, Macfarlane Burnet Institute for Medical Research and Public Health (Austin Health), Heidelberg, Australia
Correspondence: Mauro S Sandrin, E-mail: m.sandrin@unimelb.edu.au
